🇵🇱StethoMe

Seсtor

Digital Health • AI Diagnostics • Remote Monitoring

Country

🇵🇱Poznań • Poland

Money raised

$2.0M

Founded

2015 

Sector: Digital Health / AI Diagnostics / Remote Monitoring  Type: Deep tech / MedTech startup  Location: Poznań, Poland  Founded: 2015  Founders: Dr. Honorata Hafke-Dys, Dr. Sławomir Pietrzyk, Wojciech Radomski, Paweł Elbanowski, Marcin Szajek  Website: stethome.com

Overview: StethoMe is a MedTech startup that has developed the world’s first AI-powered wireless stethoscope system for home use. The solution enables patients—especially children with asthma—to monitor their respiratory health remotely and share results with doctors in real time. The system combines a CE-certified medical device, a mobile app, and proprietary AI algorithms that detect abnormalities in lung sounds with higher accuracy than traditional auscultation.

Funding & Support:

  • Over $2.5 million raised in VC and grant funding
  • Backed by TDJ Pitango Ventures, Manta Ray VC (Sebastian Kulczyk), RST Ventures for Earth, Movens VC, and others
  • Supported by EU innovation grants and Polish public funding instruments
  • Participated in multiple accelerator programs across Europe

Clients & Recognition:

  • Used in hospitals and clinics across Poland, France, and Spain
  • Partnered with platforms like MaQuestionMedicale and HomeDoctor
  • Deployed during the COVID-19 pandemic in infectious disease hospitals
  • AI algorithms shown to outperform pulmonologists in detecting pathological lung sounds (by up to 29%)

Products:

  • StethoMe® Device – wireless stethoscope for home use
  • StethoMe® App – mobile platform for guided exams and data sharing
  • AI Diagnostic Engine – proprietary algorithms for respiratory analysis
  • Cloud Dashboard – for physicians to monitor and assess patient data remotely

Investment Status: StethoMe is a VC-backed private company focused on commercialization and international expansion. While not currently raising a public round, it remains open to strategic partnerships and investor interest in the digital health and AI diagnostics space.

🔹 Stage: Growth / Commercialization

🔹 Business Model: B2B2C / SaaS / Device-as-a-Service

🔹 Strengths: CE-certified medical device, proprietary AI, pediatric focus, proven clinical use